KRAS and non-small cell lung carcinoma: Carcinogenic Kirstein Rat Sarcoma viral oncogene homolog (KRAS) mutation is the most common mutation in NSCLC, accounting for approximately 30% of adenocarcinomas and 5% of squamous lung cancers.